[
1. Gupta K, Grigoryan L, Trautner B. Urinary tract infection. Ann Intern Med. 2017;167(7):49-64.10.7326/AITC201710030
]Search in Google Scholar
[
2. Karam MRA, Habibi M, Bouzari S. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against uropathogenic Escherichia coli. Mol Immunol. 2019;108:56-67.10.1016/j.molimm.2019.02.007
]Search in Google Scholar
[
3. Redder JD, Leth RA, Møller JK. Analysing risk factors for urinary tract infection based on automated monitoring of hospital-acquired infection. J Hosp Infect. 2016;92(4):397-400.10.1016/j.jhin.2015.12.009
]Search in Google Scholar
[
4. Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin. 2014;28(1):1-13.10.1016/j.idc.2013.09.003
]Search in Google Scholar
[
5. Forsyth VS, Armbruster CE, Smith SN, Pirani A, Springman AC, Walters MS, et al. Rapid growth of uropathogenic Escherichia coli during human urinary tract infection. MBio. 2018;9(2):e00186-18.10.1128/mBio.00186-18
]Search in Google Scholar
[
6. McLellan LK, Hunstad DA. Urinary tract infection: pathogenesis and outlook. Trends Mol Med. 2016;22(11):946-57.10.1016/j.molmed.2016.09.003
]Search in Google Scholar
[
7. Smelov V, Naber K, Johansen TEB. Improved classification of urinary tract infection: future considerations. Eur Urol Suppl. 2016;15(4):71-80.10.1016/j.eursup.2016.04.002
]Search in Google Scholar
[
8. Mann R, Mediati DG, Duggin IG, Harry EJ, Bottomley AL. Metabolic adaptations of uropathogenic E. coli in the urinary tract. Front Cell Infect Microbiol. 2017;7:241.10.3389/fcimb.2017.00241
]Search in Google Scholar
[
9. Gomila A, Shaw E, Carratalà J, Leibovici L, Tebé C, Wiegand I, et al. Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections. Antimicrobiol Res Infect Control. 2018;7(1):1-11.10.1186/s13756-018-0401-6
]Search in Google Scholar
[
10. Mody L, Juthani-Mehta M. Urinary tract infections in older women. JAMA. 2014;311:844-54.10.1001/jama.2014.303
]Search in Google Scholar
[
11. Sadowska M. Dowodzenie związku przyczynowo-skutkowego w sprawach o zakażenia szpitalne. Studia Prawnicze KUL. 2017;3:107-20.10.31743/sp.3299
]Search in Google Scholar
[
12. Ziółko A. Czynniki ryzyka związane z rozpoznawaniem i zapobieganiem zakażeniom szpitalnym. Forum Zakażeń. 2016;7:109-13.10.15374/FZ2016017
]Search in Google Scholar
[
13. Edwardson S, Cairns C. Nosocomial infections in the ICU. Anaesth Intensive Care Med. 2019;20(1):14-8.10.1016/j.mpaic.2018.11.004
]Search in Google Scholar
[
14. Khan HA, Baig FK, Mehboob R. Nosocomial infections: Epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed. 2017;7(5):478-82.10.1016/j.apjtb.2017.01.019
]Search in Google Scholar
[
15. Walker E, Lyman A, Gupta K, Mahoney MV, Snyder GM, Hirsch EB. Clinical management of an increasing threat: outpatient urinary tract infections due to multidrug-resistant uropathogens. Clin Infect Dis. 2016;63(7):960-5.10.1093/cid/ciw396
]Search in Google Scholar
[
16. Santajit S, Indrawattana N. Mechanisms of antimicrobial resistance in ESKAPE pathogens. BioMed Res Int. 2016;2475067.10.1155/2016/2475067
]Search in Google Scholar
[
17. Wilson APR, Livermore DM, Otter JA, Warren RE, Jenks P, Enoch DA, et al. Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party. J Hosp Infect. 2016;92:S1-S44.10.1016/j.jhin.2015.08.007
]Search in Google Scholar
[
18. Paniagua-Contreras GL, Monroy-Pérez E, Rodríguez-Moctezuma JR, Domínguez-Trejo P, Vaca-Paniagua F, Vaca S. Virulence factors, antibiotic resistance phenotypes and O-serogroups of Escherichia coli strains isolated from community-acquired urinary tract infection patients in Mexico. J Microbiol Immunol Infect. 2017;50(4):478-85.10.1016/j.jmii.2015.08.005
]Search in Google Scholar
[
19. Tenney J, Hudson N, Alnifaidy H, Li JTC, Fung, KH. Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: a systematic literature review. Saudi Pharmaceutical J. 2018;26(5):678-84.10.1016/j.jsps.2018.02.023
]Search in Google Scholar
[
20. Li X, Chen Y, Gao W, Ye H, Shen Z, Wen Z, Wei J. A 6-year study of complicated urinary tract infections in southern China: prevalence, antibiotic resistance, clinical and economic outcomes. Ther Clin Risk Manag. 2017;13:1479.10.2147/TCRM.S143358
]Search in Google Scholar
[
21. Aguinaga A, Gil-Setas A, Alvaro A, García-Irure JJ, Navascués A. Uncomplicated urinary tract infections. Antimicrobial susceptibility study in Navarre. In Anales del Sistema Sanitario de Navarra. 2018;41(1):17-26.10.23938/ASSN.0125
]Search in Google Scholar
[
22. Bollestad M, Vik I, Grude N, Blix HS, Brekke H, Lindbaek M. Bacteriology in uncomplicated urinary tract infections in Norwegian general practice from 2001-2015. BJGP Open. 2018;1(4).10.3399/bjgpopen17X101145
]Search in Google Scholar
[
23. Karam G, Chastre J, Wilcox MH, Vincent JL. Antibiotic strategies in the era of multidrug resistance. Crit Care. 2016;20(1):1-9.10.1186/s13054-016-1320-7
]Search in Google Scholar
[
24. Masajtis-Zagajewska A, Nowicki M. New markers of urinary tract infection. Clin Chim Acta. 2017;471:286-91.10.1016/j.cca.2017.06.003
]Search in Google Scholar
[
25. Rohde C, Wittmann J, Kutter E. Bacteriophages: A therapy concept against multi-drug – resistant bacteria. Surg Infect. 2018;19(8):737-44.10.1089/sur.2018.184
]Search in Google Scholar
[
26. Lin DM, Koskella B, Lin HC. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther. 2017;8(3):162.10.4292/wjgpt.v8.i3.162
]Search in Google Scholar
